semaglutide patent expiration canada Generic Ozempic coming to Canada: what the expiry means for people with diabetes – Endor Health Walk-In Maps Patent Timeline Behind

Impact of Mediterranean Diet on Chronic Non-communicable Diseases and Longevity

Gastrointestinal side effects represent the most common adverse reactions to GLP-1 medications, with frequencies varying by agent but often affecting 20-40% of patients according to product information

Analysis of partially observed clustered data using generalized estimating equations and multiple imputation

For people prioritizing cardiovascular safety, semaglutide currently has the strongest evidence base, with two completed cardiovascular outcomes trials showing clear benefit

In this article, we explore the concept of GLP1 access equity and offer practical solutions for clinicians, health systems, and policymakers to ensure fair treatment access for all, especially amid limited supply and high demand